Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q1 2022 · 10-Q
Revenue$5.03M$5.03M+24.8% vs Q1 2021 Net Income-$3.96M-$3.96MN/M vs Q1 2021 EPS Diluted-$0.17-$0.17N/M vs Q1 2021 Gross Profit$3,231,000+23.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flow-$4,269,000N/M Free Cash Flowderived-$4,338,000N/M Margins · derivedGross margin64.2%−0.6 pt vs Q1 2021
Operating margin-76.8%−22.7 pt vs Q1 2021
Net margin-78.7%−15.7 pt vs Q1 2021
ended Mar 31, 2022 · filed May 11, 2022 · 41 d after period end